E2f3 in tumor macrophages promotes lung metastasis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The Retinoblastoma (Rb)-E2F pathway regulates the cell cycle and is often dysregulated in cancer.
• E2F transcription factors control cell proliferation, survival, and differentiation.
• Tumor-associated macrophages (TAMs) are implicated in promoting tumor invasion and metastasis.

Purpose of the Study:

• To investigate the role of E2f3 in TAMs within the tumor microenvironment.
• To determine if targeting E2f3 in TAMs can inhibit metastasis.
• To identify the molecular mechanisms by which E2f3 influences metastasis.

Main Methods:

• Utilized the MMTV-PyMT mouse model for mammary ductal carcinoma.
• Genetically ablated E2f3 specifically in TAMs and in tumor epithelial cells.
• Performed histological analysis and gene expression profiling.
• Analyzed E2f3a and E2f3b isoform levels in TAMs.

Main Results:

• Ablation of E2f3 in TAMs, but not tumor cells, significantly reduced lung metastasis without impacting primary tumor growth.
• E2f3 in TAMs regulates genes involved in cytoskeleton rearrangement, cell migration, and adhesion, not TAM proliferation or survival.
• An E2f3-dependent gene signature in TAMs could predict breast cancer recurrence and patient survival.
• Elevated E2f3b, but not E2f3a, levels were observed in TAMs from PyMT mammary tumors.

Conclusions:

• E2f3 is a critical transcription factor in TAMs that promotes breast cancer metastasis.
• Targeting E2f3 in TAMs represents a potential therapeutic strategy to inhibit metastasis.
• E2f3 influences the tumor microenvironment by modulating TAM behavior and gene expression related to cell motility.